EXTRA STRENGTH PAIN RELIEVER
- Product NDC
- 57896-216
- Requested package NDC
- 57896-216-01
- 11-digit product format
- 578960216
- Labeler code
- 57896
- Product ID
- 57896-216_43cfdcf7-0ae9-3cf5-e063-6294a90a5e7b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- ACETAMINOPHEN, ASPIRIN AND CAFFEINE
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Geri-Care Pharmaceutical Corp
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-02-01
- Substance
- ACETAMINOPHEN; ASPIRIN; CAFFEINE
- Active strength
- 250; 250; 65 mg/1; mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 57896-216 | 57896-216-01 | I | Inactivated by FDA | excluded / ndc_excluded.zip | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 57896-216 | 57896-216-01 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 57896-216 | 57896-216-01 | I | Inactivated by FDA | excluded / ndc_excluded.zip | bd6a592717d7… | 303034d00443… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- EXTRA STRENGTH PAIN RELIEVER
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 250 mg/1 |
| ASPIRIN | 250 mg/1 |
| CAFFEINE | 65 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| R16CO5Y76E | Internal UNII lookup |
| 3G6A5W338E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 308297 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| b670a898-2360-76e2-e053-2a95a90a3380 | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57896-216-01 | 2022-11-17 | C162847 | 48780-1 | d6a99b39-4c3c-a426-e053-dadaa90af4c2 | GC 226L (216) |
| 57896-216-01 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-4c3c-a426-e053-dadaa90af4c2 | GC 226L (216) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57896-216-01 | EXTRA STRENGTH PAIN RELIEVER | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 57896-216 | EXTRA STRENGTH PAIN RELIEVER (ACETAMINOPHEN, ASPIRIN AND CAFFEINE) TABLET, FILM COATED [GERI-CARE PHARMACEUTICAL CORP] | 3 | Current NDC, Legacy NDC, 1 package rows | 20231020_b670a898-2360-76e2-e053-2a95a90a3380.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Safety Coated Aspirin 81 mg Low Dose | ASPIRIN 81MG | Ulai Health LLC | 3d225a11-a53b-4dc2-9c25-13cab007900f | 2025-01-20 | Warnings | M013 |
| Pharbetol | ACETAMINOPHEN 325 MG | Ulai Health LLC | 55bb7e6c-e98c-48bd-b7bb-9848ff0273ca | 2025-01-20 | Warnings | M013 |
| ACETAMINOPHEN PM | ACETAMINOPHEN 500MG / DIPHENHYDRAMINE HCL 25MG | Ulai Health LLC | d4a568c9-a721-48d1-aebc-fc65444947ce | 2025-01-20 | Warnings | M013 |
| Pharbetol | ACETAMINOPHEN 500MG | Ulai Health LLC | c9d3cee1-531c-439f-ae19-07acd366aad6 | 2025-01-20 | Warnings | M013 |
| Percogesic Original Strength | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | Medtech Products Inc. | 529974c2-0121-4892-8e47-c2c447581091 | 2025-01-17 | Warnings | M013 |
| Little Remedies Childrens Fever Pain Reliever | ACETAMINOPHEN | Medtech Products Inc. | e1e44c85-d10c-4997-8f85-064cda7906eb | 2025-01-17 | Warnings | M013 |
| Stanback | ASPIRIN AND CAFFEINE | Medtech Products Inc. | caaa1313-09e4-45aa-8836-346f6a370196 | 2025-01-17 | Warnings | M013 |
| Dye Free Childrens Acetaminophen | ACETAMINOPHEN | Precision Dose Inc. | 5cc698fa-0841-4851-ae21-0aac8b40eb0a | 2025-01-16 | Warnings | M013 |
| Ecotrin | ASPIRIN | Medtech Products Inc. | 222d187b-aae6-410b-baeb-b2bd42f5c676 | 2025-01-16 | Warnings | M013 |
| Chewable Low Dose Aspirin | ASPIRIN | TARGET CORPORATION | f934e72a-2e9f-da17-e053-6394a90a1a2e | 2025-01-15 | Warnings | M013 |
| ACETAMINOPHEN 500 MG | ACETAMINOPHEN | Reliable 1 Laboratories LLC | 2651bf11-4d66-43ba-e054-00144ff88e88 | 2025-01-15 | Warnings | M013 |
| ASPIRIN 325 MG EC | ASPIRIN | Reliable 1 Laboratories LLC | 2ab8564f-f958-7512-e054-00144ff88e88 | 2025-01-15 | Warnings | M013 |
| ACETAMINOPHEN 325 MG | ACETAMINOPHEN | Reliable 1 Laboratories LLC | 25626b46-78f8-7226-e054-00144ff8d46c | 2025-01-15 | Warnings | M013 |
| Aspirin 81 mg | ASPIRIN | Reliable 1 Laboratories LLC | b247fe39-7f65-e502-e053-2a95a90a08f1 | 2025-01-15 | Warnings | M013 |
| Pharbetol | ACETAMINOPHEN 500MG | Ulai Health LLC | e64ce7b1-4501-4b51-b012-1882ed153b42 | 2025-01-13 | Warnings | M013 |
| Aspirin Regular Strength | ASPIRIN 325MG | Ulai Health LLC | 26942d32-d6e6-464d-8fc4-ffd9806d3e62 | 2025-01-12 | Warnings | M013 |
| ACETAMINOPHEN | ACETAMINOPHEN | WAL-MART STORES INC | a354b24e-0913-829f-e053-2995a90ad407 | 2025-01-11 | Warnings | M013 |
| ACETAMINOPHEN | ACETAMINOPHEN | WAL-MART STORES INC | 8f221fdb-8138-c1a8-e053-2995a90a29c2 | 2025-01-11 | Warnings | M013 |
| Aspirin Low Dose | ASPIRIN | A-S Medication Solutions | 3294ba24-f198-485e-88fc-435964434b80 | 2025-01-09 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Major Pharmaceuticals | 32ea1230-f9ae-46b0-910e-05cd187cee34 | 2025-01-09 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | PSN | b670a898-2360-76e2-e053-2a95a90a3380 | 4 |
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | SCD | b670a898-2360-76e2-e053-2a95a90a3380 | 4 |
| 308297 | APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral Tablet | SY | b670a898-2360-76e2-e053-2a95a90a3380 | 4 |
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | PSN | bf365bfc-35cc-47f9-a50b-ff2b38d7316b | 1 |
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | SCD | bf365bfc-35cc-47f9-a50b-ff2b38d7316b | 1 |
| 308297 | APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral Tablet | SY | bf365bfc-35cc-47f9-a50b-ff2b38d7316b | 1 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 57896-216-01 | 57896021601 | 100 TABLET, FILM COATED in 1 BOTTLE (57896-216-01) | 2020-02-01 | 0000-00-00 | No | No | Current |